1
|
Hunger SP, Lu X, Devidas M, Camitta BM,
Gaynon PS, Winick NJ, Reaman GH and Carroll WL: Improved survival
for children and adolescents with acute lymphoblastic leukemia
between 1990 and 2005: A report from the children's oncology group.
J Clin Oncol. 30:1663–1669. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bassan R and Hoelzer D: Modern therapy of
acute lymphoblastic leukemia. J Clin Oncol. 29:532–543. 2011.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Stanulla M and Schrappe M: Treatment of
childhood acute lymphoblastic leukemia. Semin Hematol. 46:52–63.
2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Pui CH, Robison LL and Look AT: Acute
lymphoblastic leukaemia. Lancet. 371:1030–1043. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pui CH, Campana D, Pei D, Bowman WP,
Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu
M, et al: Treating childhood acute lymphoblastic leukemia without
cranial irradiation. N Engl J Med. 360:2730–2741. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Pieters R, Schrappe M, De Lorenzo P, Hann
I, De Rossi G, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster
A, et al: A treatment protocol for infants younger than 1 year with
acute lymphoblastic leukaemia (Interfant-99): An observational
study and a multicentre randomised trial. Lancet. 370:240–250.
2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Papaemmanuil E, Hosking FJ, Vijayakrishnan
J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E,
Irving JA, et al: Loci on 7p12.2, 10q21.2 and 14q11.2 are
associated with risk of childhood acute lymphoblastic leukemia. Nat
Genet. 41:1006–1010. 2009. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Trevino LR, Yang W, French D, Hunger SP,
Carroll WL, Devidas M, Willman C, Neale G, Downing J, Raimondi SC,
et al: Germline genomic variants associated with childhood acute
lymphoblastic leukemia. Nat Genet. 41:1001–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Molkentin JD: The zinc finger-containing
transcription factors GATA-4, −5 and −6. Ubiquitously expressed
regulators of tissue-specific gene expression. J Biol Chem.
275:38949–38952. 2000. View Article : Google Scholar : PubMed/NCBI
|
10
|
Evans T, Reitman M and Felsenfeld G: An
erythrocyte-specific DNA-binding factor recognizes a regulatory
sequence common to all chicken globin genes. Proc Natl Acad Sci
USA. 85:5976–5980. 1988; View Article : Google Scholar : PubMed/NCBI
|
11
|
Orkin SH: GATA-binding transcription
factors in hematopoietic cells. Blood. 80:575–581. 1992.PubMed/NCBI
|
12
|
Arceci RJ, King AA, Simon MC, Orkin SH and
Wilson DB: Mouse GATA-4: A retinoic acid-inducible GATA-binding
transcription factor expressed in endodermally derived tissues and
heart. Mol Cell Biol. 13:2235–2246. 1993. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kelley C, Blumberg H, Zon LI and Evans T:
GATA-4 is a novel transcription factor expressed in endocardium of
the developing heart. Development. 118:817–827. 1993.PubMed/NCBI
|
14
|
Heikinheimo M, Ermolaeva M, Bielinska M,
Rahman NA, Narita N, Huhtaniemi IT, Tapanainen JS and Wilson DB:
Expression and hormonal regulation of transcription factors GATA-4
and GATA-6 in the mouse ovary. Endocrinology. 138:3505–3514. 1997.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Vaskivuo TE, Anttonen M, Herva R, Billig
H, Dorland M, te Velde ER, Stenbäck F, Heikinheimo M and Tapanainen
JS: Survival of human ovarian follicles from fetal to adult life:
apoptosis, apoptosis-related proteins and transcription factor
GATA-4. J Clin Endocrinol Metab. 86:3421–3429. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kyrönlahti A, Rämö M, Tamminen M,
Unkila-Kallio L, Butzow R, Leminen A, Nemer M, Rahman N, Huhtaniemi
I, Heikinheimo M and Anttonen M: GATA-4 regulates Bcl-2 expression
in ovarian granulosa cell tumors. Endocrinology. 149:5635–5642.
2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Jääskeläinen M, Nieminen A, Pökkylä RM,
Kauppinen M, Liakka A, Heikinheimo M, Vaskivuo TE, Klefström J and
Tapanainen JS: Regulation of cell death in human fetal and adult
ovaries-role of Bok and Bcl-X (L). Mol Cell Endocrinol. 330:17–24.
2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bergman M and Ringertz N: Gene expression
pattern of chicken erythrocyte nuclei in heterokaryons. J Cell Sci.
97:167–175. 1990.PubMed/NCBI
|
19
|
Shimamoto T, Ohyashiki K, Ohyashiki JH,
Kawakubo K, Fujimura T, Iwama H, Nakazawa S and Toyama K: The
expression pattern of erythrocyte/megakaryocyte-related
transcription factors GATA-1 and the stem cell leukemia gene
correlates with hematopoietic differentiation and is associated
with outcome of acute myeloid leukemia. Blood. 86:3173–3180.
1995.PubMed/NCBI
|
20
|
Ono Y, Fukuhara N and Yoshie O: TAL1 and
LIM-only proteins synergistically induce retinaldehyde
dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia
by acting as cofactors for GATA3. Mol Cell Biol. 18:6939–6950.
1998. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang L, Dong L, Liu G, Lin Y, Zhang J, Jia
S, Lu S, Pian H, Yao B and Chen H: GATA-2 gene expression in
leukemia patients and its significance. Zhonghua Xue Ye Xue Za Zhi.
22:27–29. 2001.(In Chinese). PubMed/NCBI
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Kobayashi S, Lackey T, Huang Y, Bisping E,
Pu WT, Boxer LM and Liang Q: Transcription factor gata4 regulates
cardiac BCL2 gene expression in vitro and in vivo. FASEB J.
20:800–802. 2006.PubMed/NCBI
|
24
|
Zhang SJ, Shi JY and Li JY: GATA-2 L359 V
mutation is exclusively associated with CML progression but not
other hematological malignancies and GATA-2 P250A is a novel single
nucleotide polymorphism. Leuk Res. 33:1141–1143. 2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Haupt Y, Barak Y and Oren M: Cell
type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J.
15:1596–1606. 1996.PubMed/NCBI
|
26
|
Ferrando AA, Neuberg DS, Staunton J, Loh
ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland
DG, et al: Gene expression signatures define novel oncogenic
pathways in T cell acute lymphoblastic leukemia. Cancer cell.
1:75–87. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Goldberg JM, Silverman LB, Levy DE, Dalton
VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE and Asselin BL:
Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber
Cancer Institute acute lymphoblastic leukemia consortium
experience. J Clin Oncol. 21:3616–3622. 2003. View Article : Google Scholar : PubMed/NCBI
|
28
|
Oudot C, Auclerc MF, Levy V, Porcher R,
Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, et
al: Prognostic factors for leukemic induction failure in children
with acute lymphoblastic leukemia and outcome after salvage
therapy: The FRALLE 93 study. J Clin Oncol. 26:1496–1503. 2008.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Wang Z, Kang J, Deng X, Guo B, Wu B and
Fan Y: Knockdown of GATAD2A suppresses cell proliferation in
thyroid cancer in vitro. Oncol Rep. 37:2147–2152. 2017. View Article : Google Scholar : PubMed/NCBI
|
30
|
Walker EM, Thompson CA and Battle MA:
GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation
during development. Dev Biol. 392:283–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Castro IC, Breiling A, Luetkenhaus K,
Ceteci F, Hausmann S, Kress S, Lyko F, Rudel T and Rapp UR:
MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma.
Mol Cancer Res. 11:161–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Anttonen M, Pihlajoki M, Andersson N,
Georges A, L'hôte D, Vattulainen S, Färkkilä A, Unkila-Kallio L,
Veitia RA and Heikinheimo M: FOXL2, GATA4 and SMAD3 co-operatively
modulate gene expression, cell viability and apoptosis in ovarian
granulosa cell tumor cells. PLoS One. 9:e855452014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Färkkilä A, Andersson N, Bützow R, Leminen
A, Heikinheimo M, Anttonen M and Unkila-Kallio L: HER2 and GATA4
are new prognostic factors for early-stage ovarian granulosa cell
tumor-a long-term follow-up study. Cancer Med. 3:526–536. 2014.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Mehta G, Kumarasamy S, Wu J, Walsh A, Liu
L, Williams K, Joe B and de la Serna IL: MITF interacts with the
SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac
hypertrophy. J Mol Cell Cardiol. 88:101–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
35
|
Agnihotri S, Wolf A, Munoz DM, Smith CJ,
Gajadhar A, Restrepo A, Clarke ID, Fuller GN, Kesari S and Dirks
PB: A GATA4-regulated tumor suppressor network represses formation
of malignant human astrocytomas. J Exp Med. 208:689–702. 2011.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Soini T, Haveri H, Elo JM, Kauppinen M,
Kyrönlahti A, Salo MK, Lohi J, Andersson LC, Wilson DB and
Heikinheimo M: Transcription factor GATA-4 is abundantly expressed
in childhood but not in adult liver tumors. J Pediatr Gastroenterol
Nutr. 54:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Goldfarb AN: Coordinating red cell
differentiation with cell cycle arrest: GATA-1 activation of p21.
Cell Cycle. 9:20612010. View Article : Google Scholar : PubMed/NCBI
|
38
|
Papetti M, Wontakal SN, Stopka T and
Skoultchi AI: GATA-1 directly regulates p21 gene expression during
erythroid differentiation. Cell Cycle. 9:1972–1980. 2010.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Ku CJ, Hosoya T, Maillard I and Engel JD:
GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle
entry. Blood. 119:2242–2251. 2012. View Article : Google Scholar : PubMed/NCBI
|
40
|
Pei Y, Yao Q, Yuan S, Xie B, Liu Y, Ye C
and Zhuo H: GATA4 promotes hepatoblastoma cell proliferation by
altering expression of miR125b and DKK3. Oncotarget. 7:77890–77901.
2016.PubMed/NCBI
|
41
|
Safe S: MicroRNA-specificity protein (sp)
transcription factor interactions and significance in
carcinogenesis. Curr Pharmacol Rep. 1:73–78. 2015. View Article : Google Scholar : PubMed/NCBI
|